Telum Therapeutics has raised €18 million in a Series A [...]

Innovative Molecules has expanded its virology pipeline with a new [...]

Confo Therapeutics has presented preclinical data supporting the development of [...]

PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]

Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

BiPER Therapeutics has raised €1 million ($1.16M) to support the [...]

One-carbon Therapeutics has secured SEK 153 million (€13.9 million) in [...]

Pheon Therapeutics, a clinical-stage antibody-drug conjugate (ADC) specialist, has appointed [...]

Corteria Pharmaceuticals has launched a Phase 2 trial of its [...]